Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Kazia Therapeutics (Australia) | Researchclopedia

Back to institutions

Kazia Therapeutics (Australia)

Sydney, New South Walescompany

33

Works

238

Citations

8

h-index

Top Research Topics

Glioma Diagnosis and Treatment Cancer Genomics and Diagnostics Brain Metastases and Treatment

Top Researchers

J. A. Simpson The University of Melbourne

1,102 works36,362 citationsh-index: 95

Recent Research

Abstract PS5-08-04: A phase 1b, multi-centre, open-label, randomized study to evaluate the safety, tolerability, and clinical activity of combining paxalisib with olaparib or pembrolizumab/chemotherapy in patients with advanced breast cancer

Michelle Nottage,M. Melino,et al.

20260 citations

Angiogenesis and VEGF in Cancer

Ovarian cancer diagnosis and treatment

PARP inhibition in cancer therapy

Cancer Immunotherapy and Biomarkers

Cancer, Hypoxia, and Metabolism

Colorectal Cancer Treatments and Studies

Protein Degradation and Inhibitors

Cancer Cells and Metastasis

CRISPR and Genetic Engineering

Melinda Fitzgerald TE Connectivity (Switzerland)

328 works20,750 citationsh-index: 76

Mark Fitzgerald Children's Hospital of Philadelphia

670 works17,553 citationsh-index: 59

Lars M. Ittner UNSW Sydney

241 works15,713 citationsh-index: 64

Daniel Berg Erasmus MC

275 works10,204 citationsh-index: 48

Jeremy A. Simpson University of Guelph

179 works4,273 citationsh-index: 34

Abstract PS2-10-02: Liquid Biopsy Tracking of PI3K-mTOR Residual Disease Signatures in Metastatic Breast Cancer

M. Melino,W. Tu,et al.

20260 citations

Development of a targeted BioPROTAC degrader selective for misfolded SOD1

Christen G. Chisholm,Rachael Bartlett,et al.

20253 citations

214eP Exploratory biomarkers evaluation to enhance characterization and explore treatment response prediction in metastatic ovarian cancer patients undergoing therapy with EVT801, a highly selective VEGFR-3 inhibitor

Pierre Fons,Carlos Gomez‐Roca,et al.

20250 citations

Paediatric strategy forum for medicinal product development in diffuse midline gliomas in children and adolescents ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration

Andrew D.J. Pearson,Sabine Mueller,et al.

20256 citations

LTBK-02. EVALUATION OF PAXALISIB IN GBM AGILE PHASE 3 REGISTRATION PLATFORM TRIAL FOR NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA

Ingo K. Mellinghoff,Timothy F. Cloughesy,et al.

20242 citations